PHILADELPHIA , Nov. 18, 2025 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating the fairness of the recently announced proposed buyout of Heidrick & Struggles International, Inc. (NASDAQ: HSII) (“Heidrick”) stockholders to determine whether the buyout price undervalues the company's shares.

PITTSBURGH & CHICAGO--(BUSINESS WIRE)--This Thanksgiving, HEINZ, the global leader in condiments and market leader of US gravy,1 is turning its attention to the day after Thanksgiving with the debut of HEINZ Leftover Gravy. The first-ever squeezable bottle of HEINZ Homestyle Turkey Gravy transforms the Thanksgiving staple into a condiment perfectly poised for the ultimate leftover sandwich. Thanksgiving has evolved into more than just one meal — it's a multiday celebration. 94 percent of Americ.

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vyome Holdings Third Quarter 2025 Earnings Release.

NEW YORK--(BUSINESS WIRE)--Klarna, the global digital bank and flexible payments provider, announced today that investment funds managed by Elliott Investment Management, a U.S.-based investment firm, will purchase Klarna's U.S. Fair Financing loans, supporting the continued expansion of this product in the United States. The companies expect to facilitate a total of $6.5bn-worth of loans over the two-year term of the agreement. The agreement enables Klarna to sell part of its existing Fair Fin.

NEW YORK--(BUSINESS WIRE)--Ziff Davis, Inc. (NASDAQ: ZD), today announced its participation in two investor conferences in December. Details of the conferences are as follows: UBS Global Technology and AI Conference Location: The Phoenician, Scottsdale, AZ Date and time: December 3, 2025, 7:35 am (MT) Webcast: https://cc.webcasts.com/ubsx001/120125a_js/?entity=77_84H38W5 Barclays Global Technology Conference Location: The Palace Hotel, San Francisco, CA Date and time: December 10, 2025 Webcast:.

SAN MATEO, Calif.--(BUSINESS WIRE)--Roblox Corporation (NYSE: RBLX), an immersive gaming and creation platform, today announced it is in the process of rolling out age-based chat, following its announcement in September. Roblox will be the first online gaming or communication platform to require age checks for communication, which the company hopes sets a new industry standard. Age-based chat is designed to limit conversations to users with similar ages, as appropriate. All users can now volunt.

SMITHS FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives, has expanded its Spectrum Therapeutics portfolio in Australia with the availability of new softgel capsules, further enhancing the Company's medical cannabis offerings in the region. The formats include Spectrum Yellow Cannabis Oil Softgels (CBD 20mg), Spectrum Red Cannabis.

ANN ARBOR, Mich., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that HLS Therapeutics Inc. (TSX: HLS), the Company's partner in Canada for the development and commercialization of NILEMDO® (bempedoic acid) and NEXLIZET® (bempedoic acid and ezetimibe), has received approval from Health Canada to market NILEMDO for the reduction of LDL-Cholesterol in Canadians at risk of cardiovascular disease. Commercial launch for NILEMDO is expected in Q2 2026.

TEL AVIV, Israel, Nov. 18, 2025 (GLOBE NEWSWIRE) -- REE Automotive Ltd. (Nasdaq: REE), an automotive technology company that develops software-defined vehicle (SDV) technology solutions, today announced a strategic collaboration with Mitsubishi Fuso Truck and Bus Corporation (Mitsubishi Fuso) through a memorandum of understanding (MoU)1 to collaborate and develop a software-defined vehicle (SDV) using REE's zonal SDV architecture and x-by-wire (XBW) technology. A one-year evaluation phase has commenced with the two companies working together to convert a Mitsubishi Fuso eCanter electric truck into an SDV, powered by REE's Zonal Architecture SDV technology. This collaboration permits Mitsubishi Fuso to assess the …

PHILADELPHIA , Nov. 18, 2025 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating the recently announced proposed buyout of Electronic Arts Inc. (NASDAQ: EA) (“EA” or the "Company") shareholders to determine whether the buyout agreement is fair to the Company's investors.

MORRISVILLE, N.C.--(BUSINESS WIRE)-- #JefferiesHealthcare--Presentation will focus on its flagship MRD assay, Pathlight, accompanied by a commercial update following its favorable Medicare coverage.

LAVAL, QC / ACCESS Newswire / November 18, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), today announced that Jean-Jacques Charhon, Executive Vice President and Chief Financial Officer, will participate in a fireside chat at the 8th Annual Evercore Healthcare Conference in Coral Gables, Florida on December 2, 2025. A live audio webcast of the event will be accessible on the Investor Relations section of Bausch Health's website.

CAMBRIDGE, MASSACHUSETTS / ACCESS Newswire / November 18, 2025 / Moderna, Inc. (Nasdaq:MRNA), today announced its participation in the following upcoming investor conference: Piper Sandler's 37th Annual Healthcare Conference, on Tuesday, December 2nd at 11:00am ET A live webcast of each of the presentation will be available under "Events and Presentations" in the Investors section of the Moderna website. investors.modernatx.com.

Invests $47.0 Million in Recapitalization of a Franchisee of Swim Schools HOUSTON , Nov. 18, 2025 /PRNewswire/ -- Main Street Capital Corporation (NYSE: MAIN) ("Main Street") is pleased to announce that it recently completed a new portfolio investment totaling $47.0 million to facilitate the minority recapitalization of a leading swim school franchisee (the "Company"). Main Street partnered with the Company's existing owners and management team to facilitate the transaction, with Main Street's investment including a combination of first lien, senior secured term debt and a direct minority equity investment.

Management to Hold Conference Call at 8:30 a.m. EST TEL AVIV, Israel , Nov. 18, 2025 /PRNewswire/ -- BioLineRx Ltd.

MONTRÉAL, Nov. 18, 2025 /PRNewswire/ - BCE Inc. (TSX: BCE) (NYSE: BCE) today announced that none of its fixed rate Cumulative Redeemable First Preferred Shares, Series R (Series R Preferred Shares) will be converted into floating rate Cumulative Redeemable First Preferred Shares, Series Q (Series Q Preferred Shares) on December 1, 2025. On October 17, 2025, BCE notified holders of Series R Preferred Shares that they could elect to convert their shares into Series Q Preferred Shares subject to the terms and conditions attached to those shares.

LOS ANGELES , Nov. 18, 2025 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a clinical-stage biotechnology company focused on the development of high-purity, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections, today announced that the Company will be featured in a key opinion leader (KOL) webinar, "Redefining SoC in Complicated Staph. aureus Bacteremia to Unlock a Real Opportunity" on November 25 th, 2025 at 10:00am EST.

More Than Half Plan to Expand Their Businesses, While Many Remain Worried About Inflation, Interest Rates, Supply Chains and Healthcare Costs CHARLOTTE, N.C. , Nov. 18, 2025 /PRNewswire/ -- Small and mid-sized business owners are cautiously optimistic about the coming year, with 74% expecting revenue increases and nearly 60% planning to expand their businesses, according to the 2025 Bank of America Business Owner Report, conducted in partnership with the Bank of America Institute.

Strengthens Intellectual Property Portfolio and Provides Protection for Therapeutic Combination in Acclaim-3 Clinical Trial AUSTIN, Texas , Nov. 18, 2025 /PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX ), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced that the United States Patent and Trademark Office (USPTO) has granted Genprex a patent that covers the use of the Company's lead drug candidate, Reqorsa® Gene Therapy, in combination with PD-L1 antibodies, such as Tecentriq®, through 2037. "We continue to build protection around our lead drug candidate, REQORSA, and this new …

Advancing U.S. Microelectronics Leadership Through Strategic Collaboration Advancing U.S. Microelectronics Leadership Through Strategic Collaboration